Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021

M Zysman, BR Baptista, T Soumagne… - … Medicine and Research, 2022 - Elsevier
The previous French Society of Respiratory Diseases (SPLF, Société de Pneumologie de
Langue Française) position paper on pharmacological treatment optimization in stable …

Pharmacological treatment optimisation for stable COPD: an endless story?: Proposals from the Societe de Pneumologie de Langue Francaise

M Zysman, F Chabot, B Housset… - European …, 2017 - Eur Respiratory Soc
In recent years, several global and local guidelines, recommendations and proposals on
chronic obstructive pulmonary disease (COPD) management have been published [1–14] …

Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française

M Zysman, F Chabot, P Devillier, B Housset… - Revue des Maladies …, 2016 - Elsevier
The Société de Pneumologie de Langue Française proposes a decision algorithm on long-
term pharmacological COPD treatment. A working group reviewed the literature published …

Trends over time in COPD treatment choices by respiratory physicians: an analysis from the COLIBRI-COPD French cohort

N Roche, B Aguilaniu, PZ Li, D Hess - Respiratory Medicine, 2019 - Elsevier
Introduction Over the last decade, new evidence and many guidelines have been published
on COPD pharmacological treatments; prescriptions are often not in accordance with …

Stable COPD treatment: where are we?

N Roche - COPD: Journal of Chronic Obstructive Pulmonary …, 2018 - Taylor & Francis
The number of pharmacological treatments available for COPD has increased markedly in
the last years, mostly corresponding to new agents, combinations and devices within know …

Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients

A Bargiel, A Obojski - 2015 - Eur Respiratory Soc
Introduction: The GOLD 2011 report recommends the new approach to the management of
the COPD patients based on symptom burden and future risk of exacerbations. Aims and …

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study

C Cabrera, C Casanova, Y Martín… - … journal of chronic …, 2016 - Taylor & Francis
Introduction Guidelines recommendations for the treatment of COPD are poorly followed.
This could be related to the complexity of classification and treatment algorithms. The …

The right treatment for the right patient with COPD: lessons from the IMPACT trial

D Stolz, M Miravitlles - European Respiratory Journal, 2020 - Eur Respiratory Soc
The right treatment for the right patient with COPD: lessons from the IMPACT trial |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ …

Clinical characteristics governing treatment adjustment in COPD patients: results from the Swiss COPD cohort study

L Kleinsorge, Z Pasha, M Boesing… - Swiss medical …, 2023 - zora.uzh.ch
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a widespread chronic
disease characterised by irreversible airway obstruction [1]. Features of clinical practice and …

An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?

M Cazzola, P Rogliani, E Puxeddu, J Ora… - Expert review of …, 2018 - Taylor & Francis
Introduction: Treatment recommendations are based on randomized controlled trials (RCTs).
However, only about 1 in 20 people meet the inclusion criteria for RCTs forming consensus …